Statistics
Publications
6
Citations
567
H-Index
6
Active since
1999
Daniel D. VonHoff is an author at Translational Genomics Research Institute specializing in oncology, pharmacology, and anticancer activity.
Publications per year
1999–2017
6
6
CBS9106 is a novel reversible oral CRM1 inhibitor with CRM1 degrading activity
Keiichi Sakakibara, Naoya Saito, Takuji Sato et al. · Blood · 2011 · 118 citations
1–5 of 6